Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: John W. Andrews who wrote (9417)	6/9/1998 5:32:00 PM
From: Mkilloran	Read Replies (2) \| Respond to of 23519

John...and all....est from I/B/E/S concensus 2nd qtr -0.10 3rd qtr + 0.15 and 4th qtr 0.32 ....total for year 1998 +0.30 1999.....$1.31 Zacks est for 3rd qtr -0.10 Year end 1998 +0.18 Year end 1999 $1.30 Now the big question what script numbers were used in the est??? How many foreign countries were expected approved and by when??? And when did they est the new plant would be approved???? If the scripts recover to greater levels and Vivus gets more foreign sales quicker then we exceed estimates. Japan is still an outstanding trump card....who get's distribution rights and when???? For how much??? Milestone fee or royalty agreement as Vivus has for China....... By the end of the 3rd qtr well all have a clearer picture.......